For Healthcare Providers
M. Yang, X. Hu, L. Xie, et al.Medicine (Baltimore). 2018;97(30):e11726 A 3-item SARC-F (termed SARC-F-3 in our study) was recently suggested as a screening tool for sarcopenia. The aim of this study was to compare the diagnostic value of SARC-F-3 to SARC-F in community-dwelling older people. |
O. Theou, J.K. Sluggett, J.S. Bell, et al.J Gerontol A Biol Sci Med Sci. 2018;73(8):1090-1096 The purpose of this study was to investigate and compare whether frailty is associated with hospitalization and mortality among residents of aged care services. |
K. Uemura, H. Makizako, S. Lee, et al.Maturitas. 2018;113:26-31 Sarcopenia had a strong impact on the risk of becoming homebound. Particularly in old-old subjects, sarcopenia and physical inactivity may impair people's ability to engage in activities outside the home much more than either their mental status or their level of social participation. |
M.D. Saraiva, G.S. Suzuki, S.M. Lin, et al.Age Ageing. 2018 Jul 21. doi: 10.1093/ageing/afy104. [Epub ahead of print] Pain is prevalent in frail older adults; however, the association of pain and frailty has not been evaluated yet by a systematic assessment of prospective longitudinal studies. We aimed to assess the association of persistent pain as a risk factor for frailty incidence, using data from longitudinal studies in a systematic review and meta-analysis. |
A.M.M. Vaes, M. Tieland, N. Toussaint, et al.J Nutr. 2018;148(5):712-720 Vitamin D supplementation is proposed as a potential treatment strategy to counteract functional decline in older adults. However, data from randomized trials are either limited or inconsistent. This study investigated the effect of daily supplementation with 25-hydroxycholecalciferol [25(OH)D3] or cholecalciferol (vitamin D3) on muscle strength and physical performance in older adults. |
A. Zucchelli, D.L. Vetrano, A. Marengoni, et al.Eur J Intern Med. 2018 Jun 24. pii: S0953-6205(18)30262-0. doi: 10.1016/j.ejim.2018.06.012. [Epub ahead of print] Frailty and multimorbidity are both strongly associated with poor health-related outcomes, including mortality. Being multimorbidity one of the major determinants of frailty, we aimed to explore whether, and to what extent, frailty without multimorbidity plays an independent role in shortening life. |



